Table 2.
Types | Hepatocellular | Cholestatic | Mixed | χ 2 | p |
---|---|---|---|---|---|
HILI | 26 (3.5∗) | 2 (-3.4) | 2 (-0.5) | 14.875 | 0.001 |
DILI | 25 (-3.5) | 22 (3.4) | 5 (0.5) | ||
Most common agents implicated of DILI (Top3) | |||||
Antitumor | 7 (-0.8) | 11 (2.0) | 0 (-2.0) | 9.094 | 0.031 |
Antimicrobial | 7 (1.5) | 3 (-1.5) | 1 (0.0) | ||
Analgesic-antipyretic | 1 (-0.9) | 1 (-0.9) | 2 (3.0) |
∗Adjusted residuals appear in parentheses below observed frequencies.